NEW CASTLE, DE ·
OSHA Inspection: MARLEX PHARMACEUTICALS
Planned inspection · Safety discipline
At a glance
On , OSHA opened a planned safety inspection of MARLEX PHARMACEUTICALS in 50 MCCULLOUGH DRIVE, NEW CASTLE, DE 19720 (NAICS 325412). OSHA activity number 305953499.
OSHA opens inspections for many reasons: routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.
Where did this inspection happen?
- Establishment
- MARLEX PHARMACEUTICALS
- Site address
- 50 MCCULLOUGH DRIVE
- City
- NEW CASTLE
- State
- DE
- ZIP
- 19720
What kind of inspection was it?
- Inspection type
- Planned (H)
- Scope
- Partial (B)
- Discipline
- Safety
- Advance notice
- No
- Union status
- Non-union (N)
When did the case open and close?
- Opened
- Closing conference
- Case closed
- Last modified
- Data loaded
Establishment context
- NAICS code
- 325412
- SIC code (legacy)
- 2834
- Employees
- 30
- Ownership type
- Private (A)
Citations
3 citations on file for this inspection.
1910.23 C01
- Issued
- Jun 9, 2008
- Abate by
- Jul 12, 2008
- Penalty
- Initial $700 · Current $490 Reduced
Recent events (2)
- · I (S) $490.00
- · Z (S) $700.00
1910.106 E06 I
- Issued
- Jun 9, 2008
- Abate by
- Jun 27, 2008
- Penalty
- Initial $700 · Current $490 Reduced
Recent events (2)
- · I (S) $490.00
- · Z (S) $700.00
1910.1200 E01
- Issued
- Jun 9, 2008
- Abate by
- Jul 12, 2008
Recent events (2)
- · I (O)
- · Z (O)
More inspections in this industry (NAICS 325412)
More inspections in DE
Source
This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). OSHA publishes its own view of this case as inspection number 305953499.
Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.